Review: taking Coumadin and Montelukast sodium together


Summary

Drug interactions are reported among people who take Coumadin and Montelukast sodium together. This review analyzes the effectiveness and drug interactions between Coumadin and Montelukast sodium. It is created by eHealthMe based on reports of 2,092 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Montelukast sodium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 82,667 users)

Montelukast Sodium

Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. (latest outcomes from Montelukast sodium 3,924 users)

On Aug, 27, 2016

2,092 people who take Coumadin, Montelukast Sodium are studied.


Number of reports submitted per year:

Coumadin and Montelukast sodium drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 50.0% - (2 of 4 people)
  • 1 - 6 months: 50.0% - (3 of 6 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 100.0% - (1 of 1 people)
Montelukast Sodium:
  • < 1 month: 16.0% - (1 of 6 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 85.0% - (6 of 7 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 52.0% - (9 of 17 people)
  • male: 71.0% - (5 of 7 people)
Montelukast Sodium:
  • female: 58.0% - (10 of 17 people)
  • male: 33.0% - (2 of 6 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 83.0% - (5 of 6 people)
  • 50-59: 28.0% - (2 of 7 people)
  • 60+: 60.0% - (6 of 10 people)
Montelukast Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 40.0% - (2 of 5 people)
  • 50-59: 37.0% - (3 of 8 people)
  • 60+: 66.0% - (6 of 9 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • rash
  • fatigue
  • alopecia
  • anxiety
  • arthralgia
  • blister
  • bone pain
  • dry skin
  • emotional distress
1 - 6 months:
  • skin bacterial infection
  • dehydration
  • orthostatic hypotension
  • adrenal insufficiency
  • adrenal suppression
  • bundle branch block left
  • gastrooesophageal reflux disease
  • haematoma
  • hypocalcaemia
  • inguinal hernia
6 - 12 months:
  • pulmonary hypertension
  • anisocoria
  • asthma
  • atrial fibrillation
  • edema - peripheral, peripheral edema
  • international normalised ratio abnormal
1 - 2 years:
  • haemorrhage
  • gastrooesophageal reflux disease
  • cellulitis
  • pulmonary embolism
  • tooth abscess
  • duodenitis
  • gastric polyps
  • psoriasis
  • cough
  • depression
2 - 5 years:
  • diarrhoea
  • contusion
  • epistaxis
  • international normalised ratio increased
  • anal fissure
  • cardiac failure
  • iron deficiency anaemia
  • metabolic disorder
  • pain in extremity
  • asthma
5 - 10 years:
  • cardiac failure congestive
  • chest pain
  • myocardial infarction
  • dyspnoea
  • high platelet count
  • weight increased
  • acute respiratory failure
  • adrenal disorder
  • anaemia
  • angioplasty
10+ years:
  • pain
  • back pain
  • cognitive deterioration
  • diarrhoea
  • vomiting
  • cardiac failure
  • grand mal convulsion
  • hypoxic-ischaemic encephalopathy
  • migraine
  • respiratory failure
not specified:
  • dyspnoea
  • pain
  • atrial fibrillation
  • nausea
  • fall
  • fatigue
  • cardiac failure congestive
  • dizziness
  • pneumonia
  • chronic obstructive pulmonary disease

Most common drug interactions by gender *:

female:
  • dyspnoea
  • pain
  • fall
  • international normalised ratio increased
  • nausea
  • cardiac failure congestive
  • pneumonia
  • chest pain
  • fatigue
  • atrial fibrillation
male:
  • dyspnoea
  • atrial fibrillation
  • pain
  • fatigue
  • chronic obstructive pulmonary disease
  • hypotension
  • asthenia
  • dizziness
  • cardiac failure congestive
  • injury

Most common drug interactions by age *:

0-1:
  • orthostatic hypotension
2-9:
  • catheter related complication
  • catheter related infection
  • catheter site oedema
  • catheter site pain
  • infusion site reaction
  • pain in extremity
  • abdominal pain
  • activated partial thromboplastin time prolonged
  • anaemia
  • blood bilirubin increased
10-19:
  • dyspnoea
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • bacteraemia
  • citrobacter infection
  • liver function test abnormal
  • post procedural complication
  • pulmonary hypertension
  • drug eruption
  • abdominal discomfort
20-29:
  • joint injury
  • migraine
  • pregnancy
  • pain
  • back pain
  • abortion spontaneous
  • cardiac disorder
  • deep vein thrombosis
  • drug exposure during pregnancy
  • hypotension
30-39:
  • dyspnoea
  • pulmonary embolism
  • chest pain
  • deep vein thrombosis
  • wheezing
  • abdominal pain
  • injury
  • pain
  • anaemia
  • cardiac failure congestive
40-49:
  • hypotension
  • nausea
  • dizziness
  • fatigue
  • dyspnoea
  • anxiety
  • pain
  • hypokalaemia
  • oedema peripheral
  • pyrexia
50-59:
  • fall
  • dyspnoea
  • bronchitis
  • international normalised ratio increased
  • cellulitis
  • chest pain
  • pneumonia
  • arthralgia
  • nausea
  • anaemia
60+:
  • dyspnoea
  • atrial fibrillation
  • pain
  • fall
  • international normalised ratio increased
  • asthenia
  • fatigue
  • cardiac failure congestive
  • pneumonia
  • chronic obstructive pulmonary disease

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Montelukast sodium?

Can you answer these questions?

More questions for: Coumadin, Montelukast sodium

You may be interested in these reviews

More reviews for: Coumadin, Montelukast sodium

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Montelukast sodium (montelukast sodium) is often used to treat asthma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.